California
Duarte; City of Hope
COG ANBL00B1: Neuroblastoma Biology Studies
Los Angeles; Children's Hospital Los Angeles
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Palo Alto; Lucile Salter Packer Children's Hospital
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
San Francisco; University of California, San Francisco
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Georgia
Atlanta; AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Illinois
Chicago; University of Chicago Comer Children's Hospital
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Massachusetts
Boston; Children's Hospital Boston, Dana-Farber Cancer Institute
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Michigan
Ann Arbor; C. S. Mott Children's Hospital, University of Michigan
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Ohio
Cincinnati; Cincinnati Children's Hospital Med. Center
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder In Patients with Recurrent or Resistant Neuroblastoma IND# 68,254
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Perinatal Neuroblastoma: Expectant Observation (Children's Oncology Group Pilot Study)
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
131I-Metaiodobenzylguanidine (MIBG) with Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
A Phase I Study Of Zoledronic Acid (Zometa) with Cyclophosphamide in Children with Recurrent or Refractory Neuroblastoma and Cortical Bone Involvement
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
(ANBL0621) A Phase II Study of ABT-751 in Children with Relapsed or Refractory Neuroblastoma
Pennsylvania
Philadelphia; Children's Hospital
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Texas
Houston; Texas Children's Hospital, Baylor College of Medicine
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Neuroblastoma
Washington
Seattle; Children's Hospital and Regional Medical Center
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
Wisconsin
Madison; University of Wisconsin Medical Center
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
International
Toronto, Ontario, Canada; Hospital for Sick Children
A medical study for children with relapsed or refractory high-risk Neuroblastoma.
